Calprotectin in spondyloarthritis and gut inflammation, is it clinically meaningful?
Int J Rheum Dis
.
2023 Apr;26(4):609-612.
doi: 10.1111/1756-185X.14619.
Authors
Kuan-Kai Tung
1
,
Shih-Tien Chen
2
,
Cheng-Hung Lee
1
3
4
,
Chun-Fang Tung
5
6
,
James Cheng-Chung Wei
7
8
9
Affiliations
1
Department of Orthopedics, Taichung Veterans General Hospital, Taichung, Taiwan.
2
Department of Gastroenterology and Hepatology, Chia-Yi Hospital, Ministry of Health and Welfare, Chiayi, Taiwan.
3
Post Baccalaureate Medicine, School of Medicine, National Chung Hsing University, Taichung, Taiwan.
4
Department of Food Science and Technology, Hung Kuang University, Taichung, Taiwan.
5
Division of Gastroenterology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
6
School of Medicine, National Yang-Ming Chao-Tung University, Taipei, Taiwan.
7
Department of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
8
Institute of Medicine, College of Medicine, Chung Shan Medical University, Taichung, Taiwan.
9
Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.
PMID:
37002903
DOI:
10.1111/1756-185X.14619
No abstract available
Publication types
Editorial
MeSH terms
Biomarkers
Feces
Humans
Inflammation
Leukocyte L1 Antigen Complex*
Spondylarthritis* / diagnosis
Spondylarthritis* / drug therapy
Substances
Leukocyte L1 Antigen Complex
Biomarkers